One mechanism used by cancer cells to acquire motility and invasiveness is the epithelial-to-mesenchymal transition (EMT), which involves loss of epithelial cell-to-cell contacts and increased expression of mesenchymal proteins that mediate motility (e.g., fibronectin) (84). Here, FN1 is linked to cancer.